Showing results (2231-2240 of 6,794) with videos related to

Sort By:
Pageof 680
Clinical Therapeutics|April 11, 2001
Safety profile and tolerability of amprenavir in patients enrolled in an early access programT Scott, C Garris, M Rogers, et al.
Clinical Therapeutics|April 11, 2001
Efficacy, tolerability, and patient satisfaction with 50- and 100-mg sumatriptan tablets in those initially dissatisfied with the efficacy of 50-mg sumatriptan tabletsN Savani, V Pfaffenrath, L Rice, et al.
Clinical Therapeutics|April 11, 2001
Economic implications of early treatment of migraine with sumatriptan tabletsR K Cady, F Sheftell, R B Lipton, et al.
Clinical Therapeutics|April 11, 2001
Using forecasting models to estimate the effects of changes in the composition of claims for selective serotonin reuptake inhibitors on expendituresC S Dewa, J S Hoch, P Goering
Clinical Therapeutics|January 5, 2002
A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the quetiapine experience with safety and tolerability (QUEST) studyJ Mullen, M D Jibson, D Sweitzer
Clinical Therapeutics|January 5, 2002
Comparison of cisapride and metoclopramide for facilitating gastric emptying and improving tolerance to intragastric enteral nutrition in critically III, mechanically ventilated adultsR MacLaren, W D Patrick, R I Hall, et al.
Clinical Therapeutics|January 5, 2002
The effect of tolterodine on the pharmacokinetics and pharmacodynamics of a combination oral contraceptive containing ethinyl estradiol and levonorgestrelB Olsson, B M Landgren
Clinical Therapeutics|November 24, 1999
Current opinions on therapeutic drug monitoring of immunosuppressive drugsL M Shaw, D W Holt, P Keown, et al.
Clinical Therapeutics|December 16, 2000
Adverse events and treatment discontinuations in clinical trials of fluoxetine in major depressive disorder: an updated meta-analysisC M Beasley, S C Koke, M E Nilsson, et al.
Clinical Therapeutics|August 25, 2001
A double-blind, randomized comparison of intramuscularly and intravenously administered parecoxib sodium versus ketorolac and placebo in a post-oral surgery pain modelS E Daniels, E H Grossman, M E Kuss, et al.
Pageof 680